[1] ZHANG Y W. Selection of national essential drugs and pharmacoeconomics [J]. Chin Health Econ(中国卫生经济，2009 ，28（2：80-81.
[2] MENG R. Investigation on the selection of essential drug list in China [J]. J Chin Pharm (中国药房，2010， 24：2211-2213.
[3] ANIZA M H， OTGONBAYAR R， MUNKHTUUL Y. Importance of economic evaluation in health care decision making[J]. J Commun Health，2008， 14( 1：1-10.
[4] LI H T. To Discuss the Application of the evaluation of pharmacoeconomics in guiding clinical rational use of drug[J]. Chin Hosp Man (中国医院管理， 2007，27（3：45-47.
[5] LI Y P. National essential drugs list and drug related problems of economics[J]. Chin Lic Pharm (中国执业药师， 2009， 6 （2：30-32/
[6] TORRANCE G W. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics[J]. Pharmacoeconomics， 1996，9(6：535-559.
[7] GENG X N. An analysis of evidence-based pharmaceutical economic evaluation[J]. Chin J Pharm Econ (中国药物经济学杂志，2010，4：40-45.
[8] EFRON B. Bootsrap methods： another look at the jackknife[J]. Annu Stat， 1979， 7(1：1-26.
[9] EFRON B. Bootstrap confidence intervals： Good or bad [J]. Psych Bull， 1988，104（2：293-296.